Michal Gazi
About Michal Gazi
Michal Gazi is a Staff Scientist II at Texas Biomedical Research Institute, where he has worked since 2016, focusing on research related to vaccines and treatments for viral diseases. He has extensive experience in molecular biology and genetics, holding a Ph.D. and having previously led research at Amioru LLC and worked at various prestigious institutions.
Work at Texas Biomedical Research Institute
Michal Gazi has been employed as a Staff Scientist II at Texas Biomedical Research Institute since 2016. In this role, he conducts BSL3 and BSL4 contract studies focusing on vaccines and treatments against SARS-CoV-2 and various filoviruses, including Ebola, Sudan, and Marburg. He has developed and implemented standard operating procedures (SOPs) for various assays and techniques, such as ELISA, Luminex-based cytokine assays, nucleic acid extractions, RT-qPCR quantification, and next-generation sequencing (NGS).
Education and Expertise
Michal Gazi earned his Doctor of Philosophy (PhD) in Molecular Biology and Genetics from the University of South Bohemia in České Budějovice, completing his studies from 2000 to 2004. He also holds a Master of Science (MS) degree in Molecular Biology from the same institution, which he obtained from 1997 to 2000. His educational background supports his expertise in molecular biology and genetics, contributing to his research capabilities.
Background in Research
Prior to his current position, Michal Gazi worked at the University of Texas Medical Branch (UTMB) as a Post-doctoral researcher from 2006 to 2012 and as a Research Scientist from 2012 to 2013. He also served as a Post-doctoral fellow at Emory University School of Medicine from 2004 to 2006. His extensive background in research has equipped him with the necessary skills for leading scientific investigations.
Leadership at Amioru LLC
At Amioru LLC, Michal Gazi led scientific research and supervised the R&D group, focusing on the production of biosimilars and novel therapeutic antibodies. His leadership role involved overseeing projects and guiding the research team in developing innovative therapeutic solutions.